Literature DB >> 35385719

Optimization of Cyclic Peptide Property Using Chromatographic Capacity Factor on Permeability of Passive Cell Membrane and Human Induced Pluripotent Stem Cell-Derived Intestinal Membrane.

Ayahisa Watanabe1, Shota Uehara2, Takanori Akazawa2, Motohiro Fujiu2.   

Abstract

Cyclic peptides have attracted increasing attention as a privileged class of molecules addressing undruggable targets. Cell permeability of cyclic peptides has remained a challenging issue owing to their molecular properties. Various efficiency metrics have emerged to assess this issue. Among them, the lipophilic permeability efficiency (LPE) metric is the difference between an experimental 1,9-decadiene-water partition coefficient at pH 7.4 (log Ddec/w) and calculated octanol/water partition coefficients (ALogP). This metric provides insight into how structural changes affect permeability. Here, we demonstrate the chromatographic capacity factor (log k') of cyclic peptides using reversed-phase liquid chromatography as an alternative to log Ddec/w, which enables efficient and reliable experimental lipophilicity for the adoption of LPE in early drug discovery. The log k' indicates the passive membrane permeability of cyclic peptides and can be used to optimize passive membrane permeability in combination with other parameters. In addition, intestinal membrane permeability of cyclic peptides on human induced pluripotent stem cell-derived intestinal epithelial cells was achieved with log k' and high passive membrane permeability, although cyclic peptides are P-glycoprotein substrates. These approaches could facilitate optimization of properties of cyclic peptides for oral administration and contribute to the successful discovery and development of cyclic peptides.
Copyright © 2022 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALogP; Cell permeability; Chromatographic lipophilicity; Cyclic peptides; Human iPS-derived intestinal epithelial; P-glycoprotein; log k'

Mesh:

Substances:

Year:  2022        PMID: 35385719     DOI: 10.1016/j.xphs.2022.03.019

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.784


  1 in total

1.  Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead Optimization.

Authors:  Yoshifumi Kusumoto; Kyohei Hayashi; Soichiro Sato; Toru Yamada; Iori Kozono; Zenzaburo Nakata; Naoya Asada; Shungo Mitsuki; Ayahisa Watanabe; Chiaki Wakasa-Morimoto; Kentaro Uemura; Shuhei Arita; Shinobu Miki; Tohru Mizutare; Hidenori Mikamiyama
Journal:  ACS Med Chem Lett       Date:  2022-09-01       Impact factor: 4.632

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.